Federal health officials are requiring the manufacturers of Ambien and other insomnia medications to add the strongest label warning available about the risk of complex sleep behaviors while under the influence of the drugs, including sleep walking, sleep driving and other activities that pose serious risks when not fully alert.…
Most Americans fail to use sleeping pills safely, often combining them with other drugs that could exacerbate their side effects, according to researchers.…
The FDA sent a warning letter to the makers of Zolpimist, saying that some websites and exhibit panels downplayed the drug’s side effects and overstated its effectiveness in treating insomnia.…
New research highlights the serious risks associated with sleeping pills for older individuals, finding that they may be significantly more likely to fall and suffer a life-altering hip fracture, especially during the first weeks after starting treatment.…
A recall of thousands of boxes of generic Ambien sleeping pills comes after federal regulators determined that they were not shipped in child-proof packaging, and could pose a poison risk for children.…
A new report by the ISMP warns of increasing adverse events linked to Belsomra, the first in a new class of sleeping pills released last year.…
Researchers from Norway warn that sleeping pills may triple the risk of respiratory cancers.…
Researchers warn that the side effects of sleeping pills can increase the risk of auto accidents for new users.…
A new report highlights how short clinical trials left doctors and the FDA unprepared for the side effects of long-term Ambien use.…
A new study finds that a wide range of psychotropic drugs can result in poor birth outcomes when taken by pregnant women.…
